Mind Medicine (MindMed) Inc N.MMED.WA

Primary Symbol: MNMD Alternate Symbol(s): N.MMED.WS | N.MMED.WR | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc > can see big numbers on this one soon

<< Previous

Bullboard Posts

Next >>

Comment by MrVerbatim9800on Jun 07, 2021 10:13pm

357 Views

Post# 33345695

RE:can see big numbers on this one soon

I'm not sure about $12 (yet, it will get there), but $8 in the next couple days is very possible. I haven't seen the chart and volume look this good in quotestream on MMED since last year. Bit of a speed bump at $7 and then $8, but that is to be expected. If we get passed $8 it could go parabolic.......... GTLA

V